lntrocluction
Mast cells release histamine and other mediators of allergy in response to a variety of lgE-directed stimuli. The release is generally thought to be intimately related to an elevation of free cytosolic calcium (Foreman, 1980) which increases upon lgEreceptor stimulation (White et al., 1984) . Tbis increase of free intracellular calcium Ievels appears to be mediated by generation of inositol-trisphosphate (Beaven et al., 1984; Nakamura & Ui, 1985) . In vitro, release can also be initiated by the calciumionophore A23187, which causes a direct increase of cytosolic calcium (Foreman, 1980) . However, there is increasing evidence that an elevation of intracellular calcium within the physiological range is not sußicient to trigger mast cell mediator release (Neher & Almers, 1986) . Consequently, additional signalling pathways have been postulated that act in concert with intracellular calcium (Beaven et al., 1987; Penner & Neher, 1988; Penner, 1988) . In a recent study we identified adenosine as a candidate for such a pathway which acts 1 Author for correspondence.
by increasing the calcium-sensitivity of the release process (Lohse et al., 1988) .
Adenosine has been known for several years to enhance mediator release from different types of mast cells (Marquardt et al., 1978; Welton & Simko, 1980) . Whereas earlier studies showed that the stimulation of mast cell mediator release by adenosine is antagonized by the adenosine receptor antagonist theophylline (Marquardt et al., 1978; Church et al., 1983; Hughes et al., 1984) , more recent studies have failed to confirm this observation (Vardey & Skidmore, 1985; Leoutsakos & Pearce, 1986; Lohse et al., 1987) . The latter data suggest that the effects of adenosine on mast cell release are not mediated via typical adenosine receptors. Since adenosine uptake blockers prevent the Stimulation of mast cell histamine release by adenosine (Lohse et al., 1987) it is reasonable to assume that these effects are mediated via an intracellular site. We have suggested that the action of adenosine at this site results in an enhanced sensitivity of the release process to calcium (Lohse et al., 1988) .
In the present study we have investigated the relationship between the effects of calciummobilizing agents and adenosinein order to characterize further the site at which adenosine exerts its stimulatory effects on histamine release from rat peritoneal mast cells.
Methods

Preparation of mast cells
Rat peritoneal mast cells from male Wistar rats were obtained by peritoneal lavage with HEPES-buffered saline (washing buffer) containing (mM): NaCI 137, KCI 2.7, NaH 1 P0 4 0.4, HEPES 10, glucose 5.5 and 0.05% bovine serum albumin, pH 7.4 (adjusted with NaOH). All subsequent steps were carried out at 4°C. The cell suspension was filtered through a 250 pm nylon mesh, and the filtrate centrifuged for Smin at 120g. The pellet was resuspended in the original volume washing buffer and centrifuged as above. This washing step was repeated once and the cells resuspended in incubation buffer ( = washing buffer supplemented with 1 p.M CaC1 1 and 0.5 mM MgCI 2 ), giving a suspension of about 2 x 10 5 mast cells per ml. It has been shown previously that the effects of adenosine on histamine release are indistinguishable in crude mast cell preparations and in cells purified to >95% homogeneity (Lohse et al., 1987; 1988) .
Determination of histamine release
Approximately 80,000 cells were preincubated at 37°C for 10 min in 0.95 ml of incubation buffer together with the compounds to be investigated. This preincubation time was found to result in an optimal stimulation of release by adenosine analogues. The rdease was initiated by addition of 50 p.l of incubation buffer containing either the calcium ionophore A23187 (0.1-0.4 JLM final concentration) or the Ieetin concana valin A ( 100 pg ml-1 ).
The reaction was stopped after 10 min by placing a 900 pl aliquot on ice, followed by centrifugation at 200g for 10min at 0°C. The histamine content of both the supernatant and the pellet containing the cells were detennined by the ftuorometric method of Shore et al. (1959) , as modified by Anton & Sayre (1969) and May et al. (1971) . Histamine release was expressed as a percentage of the total histamine content (cells + medium).
Data analysis
Concentration-response data were analyzed by nonlinear nonweighted regression using a general form of the Hill-equation (Lohse et al., 1986) : 
Materials
The ionophore A23187, the adenosine uptake blocker S-(p-nitrobenzyl)-6-thioinosine (NBTI), adenosine and histamine were purchased from Sigma, München, Concanavalin A and HAM-FlO medium were obtained from Serva, Heidelberg, and orthophthaldialdehyde from Merck, Darmstadt 5'-N-ethylcarboxamido-adenosine (NECA) was a gift from Byk Gulden, Konstanz. All. other drugs were of analytical grade.
Results
Wehave previously suggested that adenosine and its metabolically stable analogues increase histamine :f
Concentration of A23187 (mol r: release from rat peritoneal mast cells initiated by calcium-mobilizing agents by sensitizing the release process to calcium (Lohse et al., 1988) . Figure 1 demonstrates this for the calcium ionophore A23187. The presence of a maximally effective concentration of the adenosine analogue NECA (10 pM) shifted the concentration-response curve of A23187 to lower concentrations, changing the EC 50 value from 0.34 pM to 0.26JtM. In the presence and absence of NECA the concentratio~-response curves were very steep with slope factors of 4.6 (control) and 5.3 (10 J'M NECA). NECA had no significant effect on the release in the absence of A23187. Figure 2 shows the concentration-response curves of adenosine and NECA in enhancing A23187-induced histamine release. Both compounds have shallow curves with slopes significantly less than 1, when a large number of experiments is averaged. One possible explanation for such shallow concentration-response curves is that they result from the averaging of a heterogeneaus population of curves. Such heterogeneity of the concentrationresponse curves has been observed for agents that inhibit histamine release from basophils by increasing adenosine 3': 5' -cyclic monophosphate (cyclic AMP). The inhibitory effects of these agents are strongly dependent on the Ievel of stimulated release: the higher the release, the lower the inhibition obtained by these agents (Tung & Lichtenstein, 1981) . In order to examine whether a similar depen- were: 0.3pM A23187: E., = 11.1%, EC 50 = 930nM; 0.35pM A23187: Eb = 29.5%, EC 50 = 215nM; 0.4pM A23187: Eb = 38.5%, EC 50 = 57nM.
dence exists for the enhancing effects of adenosine analogues we investigated their effects at different Ievels of A23187-stimulated histamine release. Figure 3a shows the concentration-response curves of NECA in enhancing the histamine release induced by 0.3, 0.35 and 0.4pM A23187. A higher Ievel of stimulation markedly reduced the EC 50 value of NECA, which is most clearly seen when the curves are normalized to their respective Emall values (Figure 3b ). lncreasing the Ievel of A23187-induced release from 10% to 35% of the total histamine content resulted in a 15 fold lower EC 50 value of NECA in enhancing this release. Thus, it appears that stronger stimulation increases the sensitivity to NECA.
This effect was also seen with adenosine itself: Figure 4 shows a plot of the EC 50 values of adenosine in enhancing histamine release versus the Ievel of release induced by either A23187 or Concanavalin A. The EC 50 values were derived from experiments analogous to those shown in Figure 3 for NECA. Again, the potency of adenosine increases when the release induced by A23187 alone increases. There is a concave relationship, with EC 50 values ranging from 0.5 JLM to 16 JLM. An apparently identical relationship was found for Concanavalin A-induced release, although higher Ievels of release could only be achieved with A23187. We have previously shown that exogenous adenosine has to be taken up via the nucleoside transporter in order to enhance mast cell mediator release (Lohse et al., 1987) . Because the nucleoside transport is a facilitated bidirectional process, the presence of nucleoside transport inhibitors traps intracellular adenosine . Therefore, if high Ievels of Stimulation sensitize mast cell histamine release to adenosine, the effects of the nucleoside transport inhibitor NBTI might be different at higher Ievels of release. lndeed, Figure 5 shows that in the absence of exogenaus adenosine, NBTI 1 JlM alone bad no effect at low Ievels of histamine release. However, NBTI markedly enhanced the release at a high Ievel of A23187-induced release. NBTI almost completely abolished the enhancing effect of exogenaus adenosine at either Ievel of prestimulation. Figure 6 shows the dependence of the enl\ancing effect of NBTI on the degree of stimulation of histamine release induced by various concentrations of A23187. There was little enhancement by NBTI when the histamine release induced by A23187 alone was below 10%, but a marked effect was observed at higher Ievels of release, reaching a maximum when the A23187-induced release exceeded 20o/o. This relationship is very similar to that seen for the EC 50 value of adenosine (Figure 4) , suggesting that it reftects the same underlying mechanism.
Discussion
Adenosine and several of its metabolically stable analogues, such as NECA, appear to stimulate histamine secretion from rat peritoneal mast cells by a mechanism distinct from Stimulation of A 2 receptors and elevation of cyclic AMP. The inhibition of this effect by the nucleoside transport inhibitor NBTI suggests that elevation of intracellular adenosine is required (Lohse et al., 1987) . The enhancement of histamine release appears to be related to an enhanced sensitivity of the release process to free intracellular calcium (Lohs~ et al., 1988) . This enhanced sensitivity was seen in the present study as a shüt of the · concentration-response curve of the calcium ionophore A23187 to lower concentrations in the presence of NECA. Tung & Lichtenstein (1981) have demonstrated that l}asophils are more sensitive to inhibitory stimuli at low Ievels of release. Our data show that the reverse is true for the enhancing effects of adenosine: the potencies of adenosine and its metabolically stable analogue NECA are markedly increased at higher Ievels of release. Thus, 100. nM NECA has almost no effect when the release is below 10% of the total histamine content, but the same concentration causes a more than half maximal enhancement when the release exceeds 40%. This dependence of the response to adenosine and its analogues on the Ievel of Stimulation is a likely explanation for the large variations of its EC 50 value and the ftat concentration-response curves when a )arge number of experiments are averaged, which has been found by various workers (Marquardt et al., 1978; Holgate et al., 1980; Welton & Simko 1980; Church et al., 1986) .
There are several reports in the Iiterature that calcium may not alone be responsible for the mediation of secretory responses (see Gomperts, 1986, and Penner, 1988 , for reviews). Our data presented here andin previous papers (Lohse et al., 1987; 1988) suggest that intracellular adenosine might represent a factor which is required in addition to an elevation of intracellular calcium for release to occur. Although more complex models can be proposed, the observation of a reciprocal enhancement of the effects of adenosine and calcium is compatible with their action at the same or closely related sites. This supports our assumption that the effects of adenosine are mediatedvia an intracellular site. However, other authors assume that adenosine acts on an atypical cell surface receptor on mast cells Marquardt et al., 1988) . Our hypothesis was based mainly on the observations that the potent nucleoside transport inhibitors NBTI and S-(p-nitrobenzyl)-6-thioguanosine (NBT9) virtually abolish the enhancement of histamine release by adenosine. Although other nucleoside transport inhibitors such as dipyridamole ha ve been found to be inactive in this respect, this may be explained by their well-known low potency in the rat (Lohse et al., 1987) . It might be speculated that NBTI and NBTG act as antagonists at an atypical adenosine receptor on mast cells. Such a hypothesis is, however, incompatible with the observation that at high Ievels of release NBTI, while still blocking the effects Qf exogenaus adenosine, has an effect comparable ·to the maximal enhancement of adenosine, i.e. would appear to be a full agonist (see Figure 5 ). Conse-' quently, we feel that an intracellular site of action of adenosine is the most sensible interpretation of our results.
This intracellular site may be related to the GE-protein postulated by Gomperts and coworkers to link elevation of cytosolic free calcium and additional signals to exocytosis (Gomperts, 1986; Howell et al., 1987; Cockcroft et al., 1987) . This hypothesis is also compatible with the observation that pretreatment of hone marrow-derived mast cells with per-, tussis toxin inhibits the enhancement of mediator release by adenosine (Marquardt & Walker, 1988) , since pertussis toxin appears to affect the putative GE-protein (Penner, 1988) . Finally, it has also been suggested that cyclic AMP exerts its inhibitory effects on mediator release at the Ievel ofGE (Penner, 1988) . According to this hypothesis there may be an integration of several stimulatory and inhibitory intracellular signals at the Ievel of GE . Whereas the inhibitory effects of cyclic AMP are reduced in the face of strong stimuli (Tung & Lichtenstein, 1981) , this paper shows that stimulatory signals may synergistically enhance each other.
Thus, intracellular adenosine and calcium may have synergistic effects on histamine release, by reciprocally increasing the sensitivity of the secretory process to the other agent. The data presented here show that physiological intracellular concentrations of adenosine are sufficient to produce these effects: first, trapping adenosine inside stimulated mast cells with NBTI can cause a considerable enhancement of histamine release, which corresponds to the effect produced by 1-3 JlM exogenous adenosine in the
